Call Options

2 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2019

Jul 30, 2019

SELL
$110.79 - $129.32 $553,950 - $646,600
-5,000 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$111.31 - $131.02 $556,550 - $655,100
5,000 New
5,000 $649,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Ursa Fund Management, LLC Portfolio

Follow Ursa Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ursa Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ursa Fund Management, LLC with notifications on news.